Stockreport

aTyr Pharma Announces Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of ATYR1923 in Japan

Ethos Technologies Inc. - Class A  (LIFE) 
Last ethos technologies inc. - class a earnings: 3/26 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: atyrpharma.com/investors-media
PDF aTyr eligible to receive up to $175 million in total payments, including $8 million upfront, plus tiered sales royalties Kyorin to fund all ATYR1923 development and com [Read more]